124 related articles for article (PubMed ID: 38490321)
1. Metabolism-dependent mutagenicity of two structurally similar tobacco-specific nitrosamines (N-nitrosonornicotine and N-nitrosoanabasine) in human cells, partially different CYPs being activating enzymes.
Chen Y; Yang Z; Zhou Z; Liu EJ; Luo W; He Z; Han W; Liu Y
Toxicology; 2024 May; 504():153774. PubMed ID: 38490321
[TBL] [Abstract][Full Text] [Related]
2. Triphenyl phosphate induces clastogenic effects potently in mammalian cells, human CYP1A2 and 2E1 being major activating enzymes.
Xie J; Tu H; Chen Y; Chen Z; Yang Z; Liu Y
Chem Biol Interact; 2023 Jan; 369():110259. PubMed ID: 36372259
[TBL] [Abstract][Full Text] [Related]
3. Induction of clastogenesis and gene mutations by carbamazepine (at its therapeutically effective serum levels) in mammalian cells and the dependence on human CYP2B6 enzyme activity.
Wang Y; Chen Y; Chen Y; Luo W; Liu Y
Arch Toxicol; 2023 Jun; 97(6):1753-1764. PubMed ID: 36995427
[TBL] [Abstract][Full Text] [Related]
4. Specific human CYP enzymes-dependent mutagenicity of tris(2-butoxyethyl) phosphate (an organophosphorus flame retardant) in human and hamster cell lines.
Luo W; Hu K; Chen Y; Wang L; Liu Y
Chem Biol Interact; 2024 May; 397():111088. PubMed ID: 38823534
[TBL] [Abstract][Full Text] [Related]
5. Human CYP enzyme-activated clastogenicity of 2-ethylhexyl diphenyl phosphate (a flame retardant) in mammalian cells.
Chen Z; Xie J; Li Q; Hu K; Yang Z; Yu H; Liu Y
Environ Pollut; 2021 Sep; 285():117527. PubMed ID: 34380225
[TBL] [Abstract][Full Text] [Related]
6. Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Environ Mol Mutagen; 2001; 38(4):339-46. PubMed ID: 11774366
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of N'-Nitrosonornicotine catalyzed by cytochrome P450 2A13 and its inhibition by nicotine, N'-Nitrosoanatabine and N'-Nitrosoanabasine.
Liu X; Zhang J; Wang L; Yang B; Zhang C; Liu W; Zhou J
Chem Biol Interact; 2016 Dec; 260():263-269. PubMed ID: 27567546
[TBL] [Abstract][Full Text] [Related]
8. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
9. Potent Clastogenicity of Bisphenol Compounds in Mammalian Cells-Human CYP1A1 Being a Major Activating Enzyme.
Yu H; Chen Z; Hu K; Yang Z; Song M; Li Z; Liu Y
Environ Sci Technol; 2020 Dec; 54(23):15267-15276. PubMed ID: 33201683
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Nitrosamide Formation in the Cytochrome P450-Mediated Metabolism of Tobacco-Specific Nitrosamines.
Carlson ES; Upadhyaya P; Hecht SS
Chem Res Toxicol; 2016 Dec; 29(12):2194-2205. PubMed ID: 27989137
[TBL] [Abstract][Full Text] [Related]
11. Potent mutagenicity of some non-planar tri- and tetrachlorinated biphenyls in mammalian cells, human CYP2E1 being a major activating enzyme.
Liu Y; Hu K; Jia H; Jin G; Glatt H; Jiang H
Arch Toxicol; 2017 Jul; 91(7):2663-2676. PubMed ID: 27913846
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.
Yamazaki H; Inui Y; Yun CH; Guengerich FP; Shimada T
Carcinogenesis; 1992 Oct; 13(10):1789-94. PubMed ID: 1423839
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Activation and Carcinogenesis of Tobacco-Specific Nitrosamine N'-Nitrosonornicotine (NNN): A Density Function Theory and Molecular Docking Study.
Fan T; Sun G; Zhao L; Cui X; Zhong R
Int J Environ Res Public Health; 2019 Jan; 16(2):. PubMed ID: 30634532
[TBL] [Abstract][Full Text] [Related]
14. Human CYP enzyme-activated genotoxicity of 2,2',4,4'-tetrabromobiphenyl ether in mammalian cells.
Song M; Wang Y; Chen Z; Gao H; Yang Z; Yu H; Liu Y
Chemosphere; 2022 Mar; 291(Pt 1):132784. PubMed ID: 34742755
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.
Kushida H; Fujita K; Suzuki A; Yamada M; Endo T; Nohmi T; Kamataki T
Carcinogenesis; 2000 Jun; 21(6):1227-32. PubMed ID: 10837014
[TBL] [Abstract][Full Text] [Related]
16. Regiospecificity in the metabolism of the homologous cyclic nitrosamines, N'-nitrosonornicotine and N'-nitrosoanabasine.
Hecht SS; Young R
Carcinogenesis; 1982; 3(10):1195-9. PubMed ID: 7172419
[TBL] [Abstract][Full Text] [Related]
17. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users.
Stepanov I; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):885-91. PubMed ID: 15824160
[TBL] [Abstract][Full Text] [Related]
18. Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s.
Styles JA; Davies A; Lim CK; De Matteis F; Stanley LA; White IN; Yuan ZX; Smith LL
Carcinogenesis; 1994 Jan; 15(1):5-9. PubMed ID: 8293548
[TBL] [Abstract][Full Text] [Related]
19. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6.
Crespi CL; Penman BW; Gelboin HV; Gonzalez FJ
Carcinogenesis; 1991 Jul; 12(7):1197-201. PubMed ID: 2070484
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine.
Wong HL; Murphy SE; Hecht SS
Chem Res Toxicol; 2005 Jan; 18(1):61-9. PubMed ID: 15651850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
